Aesther Healthcare Acquisition (AEHAW) Competitors

$0.05

0.00 (0.00%)

(As of 09/6/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Trends

AEHAW vs. ATNFW, LBPSW, AIMDW, ALVOW, ACABW, ACABU, BCDAW, BFRIW, BTMDW, and BCTXW

Should you be buying Aesther Healthcare Acquisition stock or one of its competitors? The main competitors of Aesther Healthcare Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), BioCardia (BCDAW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Aesther Healthcare Acquisition vs.

Aesther Healthcare Acquisition (NASDAQ:AEHAW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and community ranking.

: Company Net Margins Return on Equity Return on Assets
Aesther Healthcare Acquisition N/A N/A N/A
180 Life Sciences N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aesther Healthcare Acquisition N/A N/A N/A N/A N/A
180 Life Sciences N/A N/A N/A N/A N/A
: In the previous week, Aesther Healthcare Acquisition's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
Company Overall Sentiment
Aesther Healthcare Acquisition Neutral
180 Life Sciences Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aesther Healthcare Acquisition
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Aesther Healthcare Acquisition and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
Aesther Healthcare Acquisition N/A N/A
180 Life Sciences N/A N/A

Company	Net Margins	Return on Equity	Return on Assets
Aesther Healthcare Acquisition	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aesther Healthcare Acquisition	N/A	N/A	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Aesther Healthcare Acquisition	Neutral
180 Life Sciences	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aesther Healthcare Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Underperform	Outperform
Aesther Healthcare Acquisition	N/A	N/A
180 Life Sciences	N/A	N/A

Summary

Aesther Healthcare Acquisition and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Ad Porter & Company

Why billionaires are wiring money to abandoned towns

A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.

Click here for my exclusive video

Get Aesther Healthcare Acquisition News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEHAW vs. The Competition

Export to Excel

Metric	Aesther Healthcare Acquisition	Pharmaceutical Preparations Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	N/A	$7.67B	$2.01B	$7.86B
Dividend Yield	N/A	2.69%	2.55%	4.01%
P/E Ratio	N/A	18.33	27.13	17.76
Price / Sales	N/A	227.92	169.56	68.12
Price / Cash	N/A	36.94	0.26	32.40
Price / Book	N/A	6.28	1.22	4.36
Net Income	N/A	$147.59M	$170.80M	$224.31M
7 Day Performance	N/A	0.15%	-2.21%	-3.60%
1 Month Performance	N/A	17.10%	2.48%	5.27%
1 Year Performance	N/A	12.11%	6.10%	4.41%

Aesther Healthcare Acquisition Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.01 -3.0%	N/A	-36.0%	$0.00	N/A	7	Positive News Gap Down
LBPSW 4D pharma	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	$522,000.00	N/A	Gap Down
AIMDW Ainos	0 of 5 stars 0.00 / 5 stars	$0.07 flat	N/A	N/A	$0.00	$65,122.00	40	Positive News
ALVOW Alvotech	0 of 5 stars 0.00 / 5 stars	$2.50 +1.6%	N/A	+50.0%	$0.00	$306.77M	4	Positive News
ACABW Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$0.05 +161.0%	N/A	+10.0%	$0.00	N/A	4	Positive News Gap Down High Trading Volume
ACABU Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$10.99 flat	N/A	+4.0%	$0.00	N/A	4	Positive News
BCDAW BioCardia	0 of 5 stars 0.00 / 5 stars	$0.01 -1.6%	N/A	-97.6%	$0.00	$468,000.00	40
BFRIW Biofrontera	0 of 5 stars 0.00 / 5 stars	$0.05 +28.2%	N/A	N/A	$0.00	$35.24M	70	Positive News
BTMDW biote	0 of 5 stars 0.00 / 5 stars	$0.39 -11.3%	N/A	-73.5%	$0.00	$187.23M	N/A	Gap Down
BCTXW BriaCell Therapeutics	0 of 5 stars 0.00 / 5 stars	$0.29 -16.4%	N/A	-90.0%	$0.00	N/A	8	Positive News Gap Down